RNU7-137P

Across TCGA pan-cancer cohorts, RNU7-137P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU7-137P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RNU7-137P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-137P expression acts as an unfavorable survival marker, although some lineages such as HNSC and STAD show a favorable association.

OV, SARC, and PAAD are the cancer types where RNU7-137P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	II,III,IV	0.308	0.693	.004	54	view →
SARC	OS	Tertile	All	0.108	0.839	<.001	36	view →
PAAD	DFS	Tertile	All	0.166	0.480	.003	27	view →
BRCA	OS	Tertile	II,III,IV	0.206	0.567	.033	12	view →
KIRP	OS	Tertile	All	0.185	0.709	<.001	12	view →
HNSC	OS	Tertile	IV	1.000	0.718	.032	12	view →
LGG	OS	Tertile	All	0.166	0.448	.014	12	view →
STAD	DFS	Tertile	III,IV	0.616	0.282	.048	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU7-137P–OV (OS)

Open the OV breakdown →